Tietz NW. Textbook of clinical chemistry. 2nd ed. Philadelphia: WB Saunders Company; 1994.
Adelberg AM, Miller J, Doerzbacher M, Lambers DS. Correlation of quantitative protein measurements in 8-, 12-, and 24-hours urine samples for the diagnosis of preeclampsia. Am J Obstet Gynecol. 2001;185(4):804-7.
Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Phys. 2005;71(6):1153-62.
Shepard MDS, Mazzachi RD. The collection, preservation, storage and stability of urine specimens for routine clinical biochemical analysis. Clin Biochem Rev. 1983;4(1):61.
Wu X. Urinalysis: a review of methods and procedures. Crit Care Nurs Clin North Am. 2010;22(1):121-8.
Ng RH, Menon M, Ladenson JH. Collection and handling of 24-hour urine specimens for measurement of analytes related to renal calculi. Clin Chem. 1984;30(3):467-71.
Archer J. Urine analysis. In: Villiers E, Blackwood L, editors. Manual of Canine and Feline Clinical Pathology. UK: BSAVA; 2005. p. 149-68.
Khatami Z, Roohi S, Nami A, Shakeri N, Abbassi M. The method of choice in measurement of microproteinuria in developing countries. Tehran Univ Med J. 2002;60(6):470-6. [Persian]
Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327(16):1141-51.
Cunningham FG, Leveno KJ, BloomSL, Hauth JC, Gilstrap LC, Wenstrom KD. Williams Obstetrics. 22nd ed.New York: McGraw-Hill; 2005.
Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximum angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol. 2009;20(12):2641-50.
Burgess E, Muirhead N, Rene de Cotret P, Chiu A, Pichette V, TobeS. Supramaximal dose of candesartan in proteinuric renal disease. J Am Soc Nephrol. 2009;20(4):893-900.